Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 10, Issue 3, 1996, Pages 124-131

  Becker, R E ^a   Colliver, J A ^a   Markwell, S J ^a   Moriearty, P L ^a   Unni, L K ^a   Vicari, S ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholinesterase inhibitors; Alzheimer disease; Cognitive decline; Dichlorvos; Memory; Metrifonate

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; ERYTHROCYTE ENZYME; METRIFONATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ATRIUM FIBRILLATION; HICCUP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TREATMENT OUTCOME; VERTIGO;

EID: 0029792078     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601030-00003     Document Type: Article

References (0)